2001
DOI: 10.1097/00005537-200101000-00031
|View full text |Cite
|
Sign up to set email alerts
|

Target‐Controlled Infusion in Sleep Endoscopy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
32
0
4

Year Published

2008
2008
2016
2016

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 46 publications
(36 citation statements)
references
References 9 publications
0
32
0
4
Order By: Relevance
“…Although the depth of sedation (with spontaneous respiration and the ability to tolerate fiberoptic endoscopy) remained within a defined range, some authors have proposed standardizing propofol dose with use of target-controlled infusion, a proprietary technology (Diprifusor; Astra-Zeneca Inc, London, England) that calculates effect site (brain) concentration using a 3-compartment pharmacokinetic model. 19,20 This approach is well suited to demonstrating the effects of varying propofol doses, but our objective is based on the target depth of anesthesia. Instead, our work and that of others 18 has shown that different subjects will achieve a defined level of sedation at different propofol doses, so we instead targeted the depth of sedation and adjusted propofol infusion rates accordingly.…”
Section: Resultsmentioning
confidence: 99%
“…Although the depth of sedation (with spontaneous respiration and the ability to tolerate fiberoptic endoscopy) remained within a defined range, some authors have proposed standardizing propofol dose with use of target-controlled infusion, a proprietary technology (Diprifusor; Astra-Zeneca Inc, London, England) that calculates effect site (brain) concentration using a 3-compartment pharmacokinetic model. 19,20 This approach is well suited to demonstrating the effects of varying propofol doses, but our objective is based on the target depth of anesthesia. Instead, our work and that of others 18 has shown that different subjects will achieve a defined level of sedation at different propofol doses, so we instead targeted the depth of sedation and adjusted propofol infusion rates accordingly.…”
Section: Resultsmentioning
confidence: 99%
“…In 2001, Roblin [7] introduced a technique of DISE in which the blood concentration of sedative agent was treated by target-controlled infusion (TCI) 7. TCI system has been developed to provide improved convenience and control during intravenous anaesthesia.…”
Section: Introductionmentioning
confidence: 99%
“…Roblin introduced target-controlled infusion (TCI) of propofol to DISE to allow for better control of the sedation level. 5 TCI of propofol uses computer-based pharmacokinetic and pharmacodynamic models to predict and…”
mentioning
confidence: 99%